Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial

Abstract Background Low-dose naltrexone (LDN) is used widely as an off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with a high risk of bias have investigated the effect of LDN on pain associated with fibromyalgia in women, but larger and more methodolo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karin Due Bruun, Kirstine Amris, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Anders Holsgaard-Larsen, Robin Christensen, Palle Toft
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Fibromyalgia
Pain
Low dose naltrexone
LDN
RCT
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/e11833aca1794dada6f0faafbdd3d3eb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares